Autres langues SD BioSensor, Inc

Actions

A137310

KR7137310009

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
10 640 ^KRW	+0,95%		+1,43%	-6,99%

2023	SD Biosensor, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2023	CI
2023	SD Biosensor, Inc. propose de cesser l'utilisation et l'élimination de certains tests à domicile Pilot COVID-19 aux États-Unis en raison d'une contamination microbienne dans la solution d'élimination liquide.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia - Transgenic News room	29/02
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	29/01
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	29/01
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	29/01
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	29/01
SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	28/07/23
SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	27/07/23
Columbus Holding Company announced that it has received KRW 258.2251644 billion in funding from SD Biosensor, Inc	28/06/23
Columbus Holding Company announced that it expects to receive KRW 258.2251644 billion in funding from SD Biosensor, Inc	13/06/23
SD Biosensor, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
SD Biosensor, Inc. Proposes Discontuation of Use and Disposal of Specific Pilot COVID-19 At-Home Tests in the United States Due to Microbial Contamination in the Liquid Disposal Solution	04/05/23
SD Biosensor, SJL Partners Acquire Meridian Bioscience	31/01/23
SD BioSensor, Inc and SJL Partners completed the acquisition of Meridian Bioscience, Inc. from Impactive Capital LP, BlackRock, Inc., The Vanguard Group, Inc, Royce & Associates, LP and others.	31/01/23
DoubleVerify Holdings to Replace Meridian Bioscience in S&P SmallCap 600	26/01/23
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023	13/01/23
Roche teams up with Pfizer on COVID-19 awareness campaign	14/12/22
Meridian Bioscience Says Closing Date of Pending Merger With SD Biosensor, Others Pushed Back to Jan. 31	12/12/22
Meridian Bioscience Fiscal Q4 Adjusted EPS, Revenue Decline	22/11/22
SD Biosensor Records 67% Jump in Q3 Profit; Shares Up 4%	04/11/22
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use	12/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SD BioSensor, Inc

Actions

A137310

KR7137310009

Autres langues

Filtres